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Background/aim: The aim of this study was to validate the Turkish Nasal Obstruction Symptom Evaluation (T-NOSE) scale.
Materials and methods: The NOSE scale was translated into Turkish. A prospective study was conducted involving adult subjects with
nasal obstruction and a control group. The patients were divided into three groups, namely nasal septum deviation (NSD), septoplasty,
and control groups. Internal consistency, test-retest reliability, validity, responsiveness, and the magnitude of the effect of surgery were
all investigated.
Results: In total, 253 subjects were enrolled in the study. Cronbach’s alpha was 0.938 and 0.942 upon test and retest, respectively, which
proved good internal consistency. The mean kappa value was 0.82, indicating a high level of reproducibility. The difference between
postoperative and control groups was not statistically significant (P < 0.05). The T-NOSE score of the NSD group was 65.67 ± 16.77,
while it was 10.75 ± 12.25 for the control group (P < 0.01). The mean score improved following septoplasty (P < 0.001). The magnitude
of the effect of surgery was considered high. The correlation between the visual analogue scale and NOSE scores was 0.948.
Conclusion: The T-NOSE scale is a valid instrument with good internal consistency, reliability, reproducibility, validity, and
responsiveness.
Key words: NOSE, Turkish NOSE, validation

1. Introduction
Nasal obstruction is a common symptom, which is often
reported as a feeling of blockage or insufficient air flow
through the nose, and it has a multifactorial origin (1,2).
The medical or surgical treatment of nasal obstruction
is very common in rhinology practice (3–6). The
clinical diagnosis of nasal airway obstruction (NAO) is
usually based on the patient’s subjective feelings and the
physician’s assessment. Since the objective evaluation of
nasal obstruction frequently does not correlate strongly
with the patient’s subjective feelings of patency, physicians
and researchers alike have increasingly focused on patient
reported outcome measures to determine the efficacy of
treatment (7). However, due to controversies concerning
objective methods of evaluation, quality of life (QOL)
measurements have become increasingly important
and they have been used to assess the severity of NAO
over several years (8). The QOL measures provide an
opportunity to determine a patient’s subjective feelings
specific to the NAO, and they can also be used as an
outcome measurement tool in nasal surgery.
* Correspondence: okarakoc@gata.edu.tr
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The Nasal Obstruction Symptom Evaluation (NOSE)
scale was designed by Stewart et al. (3) in 2004 and it has
already been validated in French (4), Portuguese (5), Italian
(6), and Greek (9). The scale was intended to provide
an opportunity to determine the patient’s subjective
feelings. The original study on the NOSE scale reported
good internal consistency and adequate reliability, and it
suggested that the scale could be a useful tool for assessing
the impact of nasal obstruction on patients’ QOL, as well
as for assessing the outcomes of research in rhinology (3).
The NOSE scale is a simple, frequently used, and wellvalidated QOL instrument specific to NAO. It consists
of five nasal obstruction-related items that can easily
determine the severity of a patient’s complaints over the
past month. All items are scored using a five-point Likert
scale and they are scaled to a total score of 0–100, with
higher scores indicating greater nasal airway obstruction.
To the best of our knowledge, no specific QOL tool
for measuring nasal airway obstruction has previously
been validated in Turkish. The present study is therefore
intended to address this research gap. The main purpose
of this study was to adapt and evaluate a Turkish version
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of the NOSE scale (T-NOSE) and then to assess its internal
consistency, reliability, and clinical validity.

translators. The final text was prepared by an evaluation
committee composed of two professional translators.
The Turkish version of the Nose Obstruction Symptom
Evaluation (T-NOSE) scale is provided in Table 1.
2.2. Inclusion/exclusion criteria
Only adult patients with NSD who complained of nasal
airway obstruction were recruited. After recording
the patient’s detailed medical history, a complete
otorhinolaryngological examination was performed,
including a nasal endoscopy after decongestion. Each
patient completed the T-NOSE questionnaire prior to and 3
months after the surgical procedure. The exclusion criteria
were: age younger than 18 years old, revision septoplasty,
septorhinoplasty, septoplasty combined with sinus or
sleep apnea surgery, septoplasty performed to access other
sites, septum perforation, nasal valve collapse, history or
clinical evidence of chronic rhinosinusitis according to
the European Position Paper on Rhinosinusitis and Nasal
Polyps (EPOS) criteria (10), inflammatory or infectious
sinus disease, adenoid hypertrophy, head and neck
radiotherapy, sinonasal malignancy, acute facial trauma or
fracture in the past three months, craniofacial syndromes,
sarcoidosis, Wegener’s granulomatosis, uncontrolled
asthma, pregnancy, and illiteracy.
2.3. Test-retest study
The test-retest reliability was checked for the NSD and
control groups by employing the NOSE scale twice during
routine patient visits by two different physicians. Patients

2. Materials and methods
A prospective instrument validation study was carried
out involving patients with nasal obstruction associated
with nasal septum deviation (NSD) and a control
group consisting of healthy volunteers. The study was
conducted in the Otolaryngology, Head, and Neck Surgery
Department of Gülhane Military Medical School between
5 February 2015 and 5 May 2015. The subjects were
divided into three groups, namely the septoplasty group,
the NSD group, and the control group. In the septoplasty
group, septoplasty was performed to correct the NSD. In
the NSD group, the subjects did not receive any surgical
intervention and/or medical treatment during the testretest period. All subjects completed the T-NOSE scale
and a visual analogue scale (VAS) regarding the severity
of nasal obstruction. All data were collected prospectively
and each subject enrolled in the study provided written
informed consent. The study was carried out in accordance
with the requirements of the Declaration of Helsinki and
it was approved by the review board of Gülhane Military
Medical School.
2.1. Translation
The original NOSE scale was translated into Turkish by ten
otorhinolaryngologists and one professional translator. It
was then translated back into English by two native English

Table 1. Turkish version of the Nose Obstruction Symptom Evaluation (T-NOSE) scale.
Over the past month, how much of a problem were the following conditions for you?
Son bir aydır aşağıdaki şikayetler sizin için hangi düzeydeydi?
Please circle the most appropriate response.
Lütfen size göre en doğru seçeneği işaretleyin.
Not a
problem

Very mild
problem

Moderate
problem

Fairly bad
problem

Severe
problem

Sorun değil

Çok hafif

Orta dereceli

Kötü

Çok kötü

1

Nasal congestion or stuffiness
Burunda şişkinlik veya dolgunluk

0

1

2

3

4

2

Nasal blockage or obstruction
Burun tıkanıklığı

0

1

2

3

4

3

Trouble breathing through my nose
Burundan nefes almada güçlük

0

1

2

3

4

4

Trouble sleeping
Uyumada güçlük

0

1

2

3

4

5

Unable to get enough air through
my nose during exercise or exertion
Eforla yeterli nefes alamamak

0

1

2

3

4
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who had any treatment and/or acute changes in symptoms
due to a common cold/influenza/respiratory tract infection
during the test-retest period were excluded from the study.
2.4. Control study
The control group was composed of members of
the medical staff, residents, hospital staff, students,
and accompanying persons/relatives of patients who
volunteered to participate. The volunteers were asked if
they had ever been diagnosed with any nasal pathologies
accompanied by NAO, undergone a nasal surgery, or
used a nasal medication in the past three months. An
otorhinolaryngological examination, including a nasal
endoscopy, was performed for all control group subjects.
They were excluded from the study if they exhibited any
nasal pathology or gave a positive response to any of
the items given above. The NOSE scores of the control
group were compared to those of the NSD group and the
postoperative scores of the septoplasty group.
2.5. Preoperative/postoperative evaluation
The septoplasty group consisted of patients with NSD
who underwent septoplasty. These patients were evaluated
twice using the T-NOSE questionnaire, once prior to
surgery and then again 3 months postoperatively. The
postoperative T-NOSE scores were compared with those
of the control group.
2.6. Statistical analysis
The internal consistency and the test-retest reliability of
the T-NOSE scale were analyzed. Cronbach’s alpha was
used to represent and evaluate the internal consistency
of ordinal responses. The minimum acceptable value was
0.7. Pearson’s test and the kappa test were used for the testretest reliability analysis.
ANOVA testing was used for comparison of multiple
groups and the Bonferroni test was also used as a post
hoc test. They were used for correcting for multiple
comparisons of the T-NOSE scale between control and
study groups.
The responsiveness of the questionnaire was assessed
by comparing the NOSE scores before and after surgery.
After using the Kolmogorov–Smirnov test in order to
assess the normality of the distribution, the Wilcoxon
signed-rank test was used to compare two related and
dependent samples and to measure the magnitude of the
effect for the statistical evaluation.
All statistical analyses were performed using SPSS 17
statistical software.
3. Results
The total number of subjects enrolled in the study was 253.
There were 168 test subjects (85 subjects in the NSD group
and 83 subjects in the septoplasty group) and 88 healthy
subjects in the control group. All participants completed
the questionnaire by themselves without the assistance
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of medical health professionals and no questions arose
concerning how to answer the questions in the translated
scale. There were 171 male (67.6%) and 82 female (32.4%)
participants. The mean age was 28.6 ± 8.4 (range: 18–63)
years. Only one patient was not available for retesting. Two
participants in the NSD group had an acute respiratory
tract infection and hence they were excluded from the
study. A total of 82 subjects from the NSD group therefore
completed the study.
3.1. Test-retest study
The test-retest evaluation was completed for 170 (NSD
group and control group) subjects. The mean time between
the test and retest evaluation was 15.4 ± 4.2 days (range:
12–24) in all groups. The mean T-NOSE scores were 38.52
± 14.49 (range: 0–100) at the initial test and 37.85 ± 14.23
(range: 0–100) at the retest.
The Cronbach’s alphas for the total T-NOSE scores
were 0.938 and 0.942 at the initial test and the retest,
respectively, with both values suggesting very good
internal consistency within the T-NOSE scale.
The mean kappa value was 0.82. The kappa value for
the first test item was 0.77, for the second item 0.88, the
third item 0.86, the fourth item 0.83, and the fifth item
0.80. The kappa results indicated substantial agreement
(Table 2).
The mean T-NOSE score in the NSD group was 65.67
± 16.77, while the mean T-NOSE score was 10.75 ± 12.25
in the control group. The difference was statistically
significant (P < 0.01).
The Pearson correlation for the NSD group between
the test and retest scores was 0.948, which was significant
(P < 0.01).
3.1.1. Control study
The control group consisted of 88 asymptomatic
volunteers, 45 males (51.1%) and 43 females (48.9%), with
a mean age of 28.26 ± 10 (range: 18–56) years. The mean
T-NOSE score was 10.97 ± 10.75 in the control group.
The T-NOSE scale was assessed twice for the testretest study. The Pearson correlation between the first and
second T-NOSE scores in the control group was 0.968 and
the correlation was significant (P < 0.01).
3.2. Preoperative/postoperative evaluation
The septoplasty group consisted of 83 subjects, 76 males
(91.6%) and seven females (8.4%), with a mean age of 27.5
± 6.2 (range: 20–48) years. All patients were operated on
by the two senior authors of the present study (ÖK, SK).
The preoperative and postoperative T-NOSE scores were
compared. The mean preoperative T-NOSE score was 72.62
± 16.42, while the mean postoperative NOSE score was
10.97 ± 10.75. Statistically significant differences appeared
between the two groups by the Wilcoxon test results (P <
0.05) (Table 3). Furthermore, ANOVA testing was used
to assess the relationships between NSD, postoperative

KARAHATAY et al. / Turk J Med Sci
Table 2. T-NOSE scores, VAS scores, and kappa values of all groups.

T-NOSE

Test mean
value
( NSD, n: 82)

Retest
mean value
(NSD, n: 82)

Test mean value
(preoperative,
n: 83)

Test mean value
(postoperative,
n: 83)

Test mean
value (control
group, n: 88)

Retest mean
value (control
group, n: 88)

Kappa
value
(n: 170)

Q1

2.35 ± 1.11

2.43 ± 1.07

2.61 ± 1.03

0.53 ± 0.67

0.44 ± 0.65

0.4 ± 0.63

0.771

Q2

2.97 ± 0.73

2.93 ± 0.79

3.20 ± 0.72

0.65 ± 0.68

0.54 ± 0.72

0.51 ± 0.71

0.884

Q3

2.87 ± 0.77

2.82 ± 0.75

3.18 ± 0.73

0.57 ± 0.7

0.43 ± 0.7

0.38 ± 0.63

0.867

Q4

2.36 ± 1.14

2.36 ± 1.12

2.81 ± 0.93

0.18 ± 0.38

0.38 ± 0.63

0.32 ± 0.58

0.839

Q5

2.59 ± 1.15

2.52 ± 1.1

2.69 ± 0.97

0.24 ± 0.53

0.43 ± 0.72

0.40 ± 0.72

0.804

TOTAL SCORE ×
65.85 ± 16.79 65.48 ± 16.75 72.59 ± 16.33
5/MEAN

10.97 ± 10.75

11.19 ± 12.08

10.22 ± 11.71

0.82

VAS

1.2 ± 0.99

1.09 ± 1.12

0.97 ± 1.15

6.9 ± 1.85

6.7 ± 1.58

7.95 ± 1.03

Table 3. Wilcoxon test results of the preoperative and postoperative T-NOSE and VAS scores.
Mean

N

Std. deviation

Preoperative T-NOSE score

72.6220

82

16.42840

Postoperative T-NOSE score

10.9756

82

10.75654

Preoperative VAS score

7.9512

82

1.04116

Postoperative VAS score

1.2073

82

0.99055

T-NOSE, and control group scores and the Bonferroni
post hoc test was carried out to reveal the source of the
difference. The difference between postoperative and
control groups was not statistically significant (P < 0.05).
3.3. Association between the VAS score and T-NOSE items
The association between the VAS score and the items
of the T-NOSE scale was investigated using the Pearson
correlation test in the NSD and control groups (n: 170).
The patients in the surgery group could not be included
in the correlation test because their preoperative and
postoperative scores changed dramatically (preoperative
T-NOSE score: 72.62, postoperative T-NOSE score: 10.97,
Pearson correlation score: 0.19). The correlation between
the VAS and NOSE scores was 0.948, which was significant
(P < 0.01; two-tailed).
Among the included subjects, age was not significantly
correlated with the overall T-NOSE score or with each of
its items. The mean total T-NOSE score for females was
47.92 ± 29.2, while for males it was 49.08 ± 31.7.
4. Discussion
The use of disease-specific questionnaires provides
valuable and practical information for the assessment of
the impact of nasal obstruction on individuals, especially
in rhinology practice. To the best of our knowledge, no
specific QOL tool for nasal obstruction has previously

P
P: 0.003
P: 0.002

Z
Z: –7.872
Z: –7.933

been adapted into Turkish. In this study, all of the subjects
were easily able to fully complete all the questions. Hence,
this evaluation method can be described as a handy and
easily self-administered instrument.
The T-NOSE scale’s internal consistency was analyzed
and it appeared to be very good, with an overall Cronbach’s
alpha coefficient value of 0.938 and 0.942 at the initial
and retest examination, respectively. Internal consistency
refers to the way in which the items within an instrument
relate to each other (11). In the original study by Stewart et
al. (3), the overall Cronbach’s alpha coefficient was 0.785,
while in Marro et al.’s (4) and Mozzanica et al.’s (6) studies
it was 0.86 and 0.81, respectively.
The reliability of the test-retest scores of the
T-NOSE scale was a concern and so it was evaluated
statistically with Pearson’s test and the kappa test. The
Pearson test values ranged from 0.948 to 0.968, which
was considered good for all groups’ comparisons and
individual measurements over time. In the original study
(2), the test-retest correlation coefficient was 0.702, while
in Bazerra et al.’s (1) and Mozzanica et al.’s (6) studies it was
0.776 and 0.73, respectively.
We evaluated each item of the T-NOSE scale with
the kappa test, which represents the questionnaire’s
reproducibility (12). The mean value was 0.82, indicating
substantial agreement. In other words, a high level of
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reproducibility was obtained for the Turkish questionnaire.
The measurement of validity concerns the capacity
of the utilized questionnaire to distinguish differences
between patients who have or do not have the disease
being studied (4,11). In this study, the difference between
the NSD patients and the control group was statistically
significant. Additionally, the relationship between the
postoperative mean T-NOSE scores of the septoplasty and
control groups was significantly meaningful.
The correlation between the VAS and NOSE scores was
0.948, which was significantly similar to that found in the
original study (3).
Responsiveness concerns the capacity of the
questionnaire to detect clinical changes over time and it

can describe the size of the effect (7). We used a paired
t-test to evaluate responsiveness by comparing the scores
before and after surgical treatment. The NOSE scores
before and after surgery were significantly different, which
was similar to the results of previous studies (3–6).
As a limitation of the present study, since it was
conducted in a military hospital, there was a predominance
of male subjects (171 males (67.6%) vs. 82 females (32.4%)).
In conclusion, our study proves that the T-NOSE
scale has satisfactory internal consistency, reliability,
reproducibility, validity, and responsiveness in adult
Turkish patients. It is therefore a valid and useful instrument
for assessing nasal obstruction in daily practice.
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